Palantir Technologies has seen its stock price decline recently, making it an attractive target for investors looking to buy on the dip. However, three other stocks are expected to surpass Palantir’s growth in the next six years.
Alibaba (BABA) is a more appealing AI stock than Palantir, with a lower valuation ratio of 13.8 times forward earnings compared to Palantir’s 244. Alibaba’s growth will accelerate as China prioritizes AI development, making it a leader in cloud services and AI technology.
ASML (ASML), a Dutch semiconductor company, shares similar advantages that enable it to grow faster than Palantir over the next three years. Its valuation is more attractive, with a PEG ratio of 1.51 compared to Palantir’s 4.12. ASML commands a near monopoly in extreme ultraviolet lithography, a technology critical to AI applications.
UnitedHealth Group (UNH) is expected to rebound and surpass Palantir by 2028, driven by its growing addressable market and temporary issues. The company will overcome high medical costs and DOJ investigations through premium hikes and strategic maneuvering. Billionaires Warren Buffett and David Tepper have already invested in UnitedHealth, indicating its undervalued potential.
These three stocks offer attractive growth prospects, making them more suitable investments than Palantir in the next six years.
Source: https://www.fool.com/investing/2025/08/25/prediction-3-magnificent-stocks-thatll-be-worth-mo